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Combining creatinine and volume kinetics
identifies missed cases of acute kidney injury
following cardiac arrest
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Abstract
Introduction: Fluid resuscitation in the critically ill often results in a positive fluid balance, potentially diluting the
serum creatinine concentration and delaying diagnosis of acute kidney injury (AKI).
Methods: Dilution during AKI was quantified by combining creatinine and volume kinetics to account for fluid
type, and rates of fluid infusion and urine output. The model was refined using simulated patients receiving
crystalloids or colloids under four glomerular filtration rate (GFR) change scenarios and then applied to a cohort of
critically ill patients following cardiac arrest.
Results: The creatinine concentration decreased during six hours of fluid infusion at 1 litre-per-hour in simulated
patients, irrespective of fluid type or extent of change in GFR (from 0% to 67% reduction). This delayed diagnosis
of AKI by 2 to 9 hours. Crystalloids reduced creatinine concentration by 11 to 19% whereas colloids reduced
concentration by 36 to 43%. The greatest reduction was at the end of the infusion period. Fluid dilution alone
could not explain the rapid reduction of plasma creatinine concentration observed in 39 of 49 patients after
cardiac arrest. Additional loss of creatinine production could account for those changes. AKI was suggested in six
patients demonstrating little change in creatinine, since a 52 ± 13% reduction in GFR was required after
accounting for fluid dilution and reduced creatinine production. Increased injury biomarkers within a few hours of
cardiac arrest, including urinary cystatin C and plasma and urinary Neutrophil-Gelatinase-Associated-Lipocalin
(biomarker-positive, creatinine-negative patients) also indicated AKI in these patients.
Conclusions: Creatinine and volume kinetics combined to quantify GFR loss, even in the absence of an increase in
creatinine. The model improved disease severity estimation, and demonstrated that diagnostic delays due to
dilution are minimally affected by fluid type. Creatinine sampling should be delayed at least one hour following a
large fluid bolus to avoid dilution. Unchanged plasma creatinine post cardiac arrest signifies renal injury and loss of
function.
Trial registration: Australian and New Zealand Clinical Trials Registry ACTRN12610001012066.
Introduction
Resuscitation of intravascular volume of critically ill
patients is essential for hemodynamic support [1-3].
Accurate estimates of kidney function remain elusive in
the absence of real-time measurement of the glomerular
filtration rate (GFR). Plasma creatinine remains the
default surrogate biomarker of GFR [4-6]. Dilution of
plasma creatinine by fluid loading [7] is usually not con-
sidered. However, if fluid resuscitation dilutes plasma
creatinine, the incidence of acute kidney injury (AKI)
may be under-reported, diagnosis and intervention
delayed, and GFR overestimated.
Creatinine kinetic modeling and back-calculating base-
line creatinine from presumed GFR have evaluated AKI
definitions [5,8,9], identified creatinine-based outcome
metrics for clinical trials [10], quantified the effect of cal-
culated baseline creatinine on AKI epidemiology [11-13],
and compared methods of normalizing urinary injury
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biomarkers [14,15]. None of these models incorporates the
dilution effect of fluid loading on plasma creatinine con-
centration, nor do they allow for dynamic changes in crea-
tinine generation.
Volume kinetic modeling is used to simulate the distri-
bution and clearance of infused fluids [16]. It has been
used to investigate the differences in distribution of col-
loids and crystalloids in volunteers, the influence of
anesthesia and surgery on clearance [17,18], and patient
response to crystalloid infusion (for example, in women
with pre-eclampsia) [19].
We developed a model that combined volume and crea-
tinine kinetics. The model was first applied to simulated
patients to assess the extent of plasma creatinine concen-
tration change due to fluid loading and its effect on AKI
diagnosis. We then used the model to assess the changes
in renal function and creatinine generation in a cohort of
49 cardiac arrest patients. The limitations of the model
were further assessed by a detailed examination in three
patients.
Materials and methods
A two-compartment creatinine kinetic model and a two-
compartment volume kinetic model were combined into a
volume-creatinine kinetic model. The initial conditions of
the model were assessed in a simulated patient. The
model was then tested in a cohort of patients resuscitated
after cardiac surgery. Three patients were presented as
case studies. Data collection was approved by the Upper
South A Regional ethics committee of New Zealand
(URA/09/09/062). Screening on entry to the emergency
department (ED) was by presumptive consent, followed by
written consent from the patient or family.
Creatinine kinetics
The creatinine kinetic model is shown in Figure 1a. Creati-
nine generated in muscle cells enters the extravascular
compartment (V2) at a rate Ġ, is freely exchanged with the
plasma compartment (V1), and is eliminated by the kidney
at a rate determined by the rate constant, kr (note: GFR =




) and a subscript ‘0’ to represent the value of
the variable at time zero.
Given that the total volume of distribution of creati-
nine (V1 + V2) is equal to the total body water, the
extravascular volume is equal to the total body water
minus the plasma volume; it is assumed that creatinine
is not bound and flows freely from one compartment
with the same permeability as water. The rate of change
of mass in each compartment was determined by mass
balance (Table 1). Because creatinine was not bound,
the rate of exchange between compartments (ke) was
the same in both directions. Conditions at equilibrium,
where there is zero rate of change of creatinine, creati-
nine production, and compartment volumes, were used
to ascertain initial conditions for kr and kd (see Addi-
tional file 1 containing extended methods).
Volume kinetics
Volume kinetics simulates the distribution and elimi-
nation of infused fluids and usually involves two com-
partments: one approximates the plasma volume (V10
prior to expansion) and the other approximates the
expandable component of the interstitial fluid space
(Vt0 prior to expansion) [16] (Figure 1b). V2e0 is smal-
ler than the interstitial space because expansion of
body fluids is not possible in all regions (for example,
in the skeleton) [16]. As fluid is infused into the vascu-
lature, the plasma compartment volume will expand at
a rate dependent on the rate of infusion (Ḃ), metabolic
production (Ṁ), insensible loss (İ), urine output (U˙),
and exchange between compartments. The rate of
exchange between compartments depends on the dis-
tribution clearance (Cld) and the relative differences in
the expansion of the two volumes (Table 1). We
assume that water can flow freely in both directions
between compartments [16] and that there is no signif-
icant loss to a third space.
Combined creatinine kinetic and volume kinetic model
The creatinine and volume kinetic models were combined
assuming that creatinine kinetic plasma compartment and
volume kinetic plasma volume were the same [16]. The
extravascular creatinine compartment volume (V2) is equal
to the sum of the expandable (v2e) and non-expandable
(V2n0) fluid volumes: V2 = v2e + V2n0; therefore,
V˙2 = V˙2e.V2n0 equals the difference between the initial
extravascular and expandable interstitial space volumes
(V2n0 = V20 - V2e0). The model was programmed in
Matlab (Matlab 2011b; MathWorks Inc., Natick, MA,
USA) and solved numerically with the ordinary differential
equation solver ode45. Extended methods are presented in
Additional file 1.
The simulated patient
Effect of fluid loading and differential rates of urine output
The change in creatinine concentration and fluid balance
as a function of time was calculated for a 70-kg male with
total body water of 42 L, plasma volume of 2.8 L, expand-
able interstitial volume of 8.4 L [16], baseline GFR of 100
mL/minute, baseline creatinine concentration of 1 mg/dL,
and initial creatinine generation rate of 1 mg/minute,
which decreased by 1.5% per day [20,21]. Simulated
patient demographics are presented in Table 2.
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Urine output
The rate of urine output depends on hydration status. In
someone with normal kidney function, extreme hyper-
tonic dehydration (loss of 10% of total body water)
results in approximately a 70% reduction in urine output
[22,23], whereas overhydration will produce a rapid
increase in urine output, peaking at approximately 900





















Figure 1 Creatinine kinetic model (a) and volume kinetic model (b). C1 and C2, creatinine concentrations of the plasma (1) and extracellular
(2) compartments, respectively; Cld, distribution clearance; G, creatinine generation rate; ke, rate constant for creatinine diffusion between
compartments; kr, rate constant for creatinine excretion; v, expanded volume; V1 and V2, creatinine volumes of the plasma (1) and extracellular
(2) compartments, respectively; V2e, volume of the expandable compartment.
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a formula to describe change in urine output (Additional
file 1). Failure of reabsorption results in polyuric AKI,
which was not modeled.
Fluid input
Two fluid input scenarios were modeled: (a) maintenance
fluid alone and (b) maintenance + boluses of either crystal-
loids or colloids of 1 L per hour for 6 hours beginning at
the end of hour one. This represents a high fluid input
and corresponded to the 80th percentile of the fluid input
over the course of the first 6 hours of the patients in the
cardiac arrest cohort. For each fluid input scenario, there
were four GFR scenarios: no change in GFR and a
decrease by one third, one half, or two thirds at the time
of insult (t = 1 hour). These correspond to GFR criteria
for RIFLE AKI severity stages R (Risk), I (Injury), and F
(Failure). On the basis of creatinine kinetic modeling
alone, these produce creatinine increases of 50%, 100%,
and 200%, respectively [9].
The crystalloid distribution exchange rate (Cld) was set
at 200 mL/minute. This was based on multiple studies
with Ringer’s lactate (Table S3 in Additional file 1).
Colloids have much longer half-lives in the vasculature
[1,24,25] and correspondingly smaller distribution
exchange rates. Cld for colloids was set at 10 mL/minute.
Metabolic water production was assumed to be 400 mL/
day (16.7 mL/hour), and insensible losses 800 mL/day
(33.4 mL/hour). At a GFR of 100 mL/minute followed
by 99% reabsorption, urine output was 1 mL/minute
(60 mL/hour). Therefore, maintenance fluid was set at
76.7 mL/hour (maintenance = U˙ + (I˙ − M˙)) .
Sensitivity analysis
The sensitivity of the model was assessed for differences in
Cld (50, 100, 300, and 400 mL/minute compared with 200
mL control), the difference between insensible loss and
metabolic water production (0 and 800 mL compared
with 400 mL control), the ratio of the plasma volume to
volume of expandable interstitial space (1:2 and 1:4 ratios
compared with 1:3 control), and a loss or gain of creati-
nine production for the duration of the illness (30%).
Patient cohort
Patients admitted following cardiac arrest were a subco-
hort from the Early Detection of Acute Kidney Injury
(EDAKI) study conducted in the ED and intensive care
unit of Christchurch Hospital (Christchurch, New Zeal-
and). Ethics approval was obtained from the Upper South
A Regional Ethics Committee (URA/09/09/062), and
informed consent was obtained from patients or relatives.
After ICU admission, each patient immediately under-
went therapeutic hypothermia for 24 hours (core tem-
perature reduced to 33°C). The resuscitation fluid was
0.9% saline in each case prior to arrival at the ED. Hourly
urine output and fluid input were recorded for each
patient. Plasma samples were collected on admission to
the ED, on admission to the ICU, and at least daily there-
after. Urine samples for measurement of neutrophil gela-
tinase-associated lipocalin (NGAL), cystatin C, alkaline
phosphatase (ALP), gamma-glutamyltranspeptidase
(GGT), and a- and π-glutahione-S-transferase (a- and
π-GST) were taken on catheterization in the ED, on
admission to the ICU, and 4, 8, and 16 hours later and
daily.
To assist assessment, patients were divided into three
groups: Crincrease (a plasma creatinine increase of more
than 20% at 24 hours after cardiac arrest), Crdecrease
(a plasma creatinine decrease of more than 10% at
24 hours), and Crunchanged (neither Crincrease nor Crdecrease).
The first male enrolled in each group was selected as a
case study:
Patient A was a 90-kg male with a history of hyper-
trophic obstructive cardiomyopathy and with severely
impaired left ventricular function (ejection fraction of
25%). He had presented to the ED, complaining of
abdominal pain, nausea, and vomiting. His condition
deteriorated, requiring intubation, during which time he
Table 1 Creatinine and volume kinetic components
Compartment Rate of change of
mass/volume
Gain Losses
Creatinine 1 C˙1V1 + C1V˙1 keC2V2 keC1V1 +
krC1V1
Creatinine 2 C2V˙2 + C˙2V2 Ġ + keC1V1 keC2V2
Plasma, 1 V˙1 Ḃ + Ṁ I˙ + U˙ + V˙2e










C2, creatinine concentrations for compartments 1 and 2, respectively. vc and
vt, time-varying volumes; V1 and V2, creatinine volumes for compartments
1 and 2, respectively. V10 and V2e0, time zero compartment volumes.
Table 2 Simulated virtual-in-patient demographics
Ideal total body water (ITBW), mL 42,000
Initial plasma volume (V10), mL 2,800 (ITBW/15)
Initial expandable space volume (V2e0), mL 8,400 (3 × ITBW/15)
Initial creatinine generation rate (Ġ0),
mg/minute
1
Glomerular filtration rates 100, 66.7, 50, 33.3
Insensible water loss rate (İ), mL/day 800
Metabolic water generation rate (Ṁ), mL/day 400
Distribution clearance rate (Cld), mL/minute 200, 10
Initial plasma creatinine concentrations
(C10 ≡ C20), mg/dL
1
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suffered a cardiac arrest followed by cardiopulmonary
resuscitation (CPR). He was defibrillated twice (at 360 J),
and adrenaline was given. After 50 minutes, he regained
cardiac output and was transferred to the ICU. Over the
next 4 days, his cardiopulmonary status improved stea-
dily; however, presumably owing to hypoxic brain injury,
there was no neurological recovery. Therapy was with-
drawn and he died.
Patient B was an 87-kg male with a history of alcohol-
ism. He collapsed during a shower. Resuscitation time
was 20 minutes with marginal CPR. He received 1.5 L of
normal saline in the ED and 1 L in the first two hours in
the ICU. Prognosis was assessed as poor after rewarming.
Multiple fluid boluses were given, but the patient became
oliguric and died 53 hours after arrest.
Patient C was an 80-kg male with no medical history.
He suffered a cardiac arrest during a motor vehicle
inspection. Immediate CPR was performed by a nurse
bystander before the arrival of paramedics. Resuscitation
lasted 27 minutes with defibrillation (once) and two adre-
naline boluses. An electrocardiograph showed an infero-
lateral myocardial infarct, and the patient underwent
emergency percutaneous coronary intervention with a
stent inserted to repair the left circumflex artery, which
was completely occluded. He was transferred to the ICU
for cooling. There were several occasions of bradycardia
needing boluses of atropine and later adrenaline infusion.
After rewarming, his condition improved and he was
extubated. He was discharged to a coronary care unit on
day 3. Model application to the cardiac arrest patients
used the measured urine output from each patient rather
than the simulated urine output of the simulated patient.
Results
Model application in simulated patients
Glomerular filtration rate maintained
Creatinine concentration decreased as fluid was infused,
and plasma volume increased while GFR was held constant
(Figure 2). The minimum concentration at the end of the
infusion was 19% below the starting concentration for the
crystalloid infusion and 36% below for the colloid infusion.
The concentration returned to normal within about
6 hours after crystalloid infusion but took an additional
approximately 10 hours after colloid infusion. Colloid infu-
sion produced an increase in creatinine concentration
above baseline from 2 to approximately 16 hours following
infusion. During this period, renal elimination of excess
body water occurred at a rate greater than the flow of
water from the extravascular space into the plasma, result-
ing in a brief decrease in plasma volume. Urine output
peaked at 825 mL/hour at the end of the fluid bolus, at
which time the simulated patient was 5.7% overhydrated. It
required a further 6 hours before urine output decreased
below 100 mL/hour.
Glomerular filtration rate decreased
Even with concomitant loss of GFR, there was a reduction
in plasma creatinine during fluid infusion. This reduction
was similar irrespective of the degree of GFR decrease.
After fluid administration, the increase in creatinine was
smaller than expected in AKI based on creatinine kinetic
modeling alone (Figure 3), except for a brief period follow-
ing colloid infusion when there was a transient increase in
creatinine above that predicted by creatinine kinetics
alone. Diagnosis of AKI was delayed by 2 to 9 hours by
administration of fluids, depending on the extent of loss of
GFR and type of fluid administered.
Sensitivity analysis
A sensitivity analysis of input variables was performed for
patients receiving 6 L of crystalloid the course of 6 hours
with no change in GFR. The model was insensitive to dif-
ferences in the rate of water distribution, ranging from 50
to 400 mL/minute, with a maximum difference in plasma
creatinine concentration of 8.9%. The model was even less
sensitive to a ± 400 mL/day difference between insensible
loss and metabolic water production, with a maximum dif-
ference of 4.7%. Similarly, the model was insensitive to
variations in the ratio of the plasma to expandable space
(V10 to Ve0), with maximum differences in creatinine con-
centration from the 1:3 V10 to Ve0 ratio of -5.5% (1:2 ratio)
and 3.6% (1:4). A decrease of 30% in creatinine generation
maintained for 72 hours led to a 30% decrease in plasma
concentration (Additional file 1).
Model application to patients after cardiac arrest
Forty-nine patients were enrolled on entry to the ED.
Patient demographics and initial parameters are shown
in Table 3 for all 49 patients and in Table 4 with addi-
tional model parameters for the three case studies.
Three main patterns of change in creatinine concentra-
tion were observed during the first 24 hours: a rapid
increase (Crincrease: n = 4), little change (Crunchanged: n =
6), or a rapid decrease (Crdecrease: n = 39) (Figure 4).
Crincrease patients were all designated as clinical AKI by
the Acute Kidney Injury Network (AKIN) definition
(> 0.3 mg/dL increase in plasma creatinine within
48 hours). The Crunchanged group showed fluctuations
between a 20% increase and a 10% decrease in creati-
nine relative to the initial ED concentration. Patients
had a relative reduction of 14% to 47% (median 32%,
IQR 21% to 39%) within 24 hours. In the Crdecrease
group, the plasma cystatin C concentrations also had a
relative reduction of 6% to 41% (median 37%, IQR 28%
to 43%), and urinary creatinine concentrations were low
or rapidly decreased. All in the Crincrease, 5 of 6 Crunchanged,
and 36 of 39 Crdecrease groups had urine outputs of less
than 0.5 mL/hour per kg for at least 6 hours for any
6-hour period during the first 48 hours (AKIN urine out-
put AKI criterion).
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Creatinine decrease (Crdecrease)
Applying the volume-creatinine kinetic model while
assuming no loss of GFR showed that dilution could
explain 43% (IQR 26% to 67%) of the maximum reduction
in creatinine concentration in the Crdecrease patients within
the first 24 hours. The remaining reduction in creatinine
concentration may be explained and modeled as a loss of
creatinine production (Figure 5) or an increase in GFR
assuming patients had AKI on admission.
Creatinine unchanged (Crunchanged)
Over the course of the first 24 hours, a mean 52% (stan-
dard deviation 13%) decrease in GFR was required to
account for the lack of reduction in plasma creatinine
taking into account fluid input and urine output and
assuming a loss of creatinine production the same as the
median loss for the Crdecrease cohort (Figure 5b). Multiple
injury biomarkers were increased in the Crunchanged
patients: plasma NGAL (P < 0.01), urinary NGAL (P <
0.01), and urinary cystatin C (P < 0.01) compared with
the Crdecrease cohort (Figure 6). All 10 of the Crincrease or
Crunchanged patients died within 30 days, whereas 13 of
the 39 Crdecrease patients died (P < 0.0001).
Case studies
Case A: Crincrease
AKI was detected 11 hours 46 minutes after cardiac
arrest (plasma creatinine of 1.36 mg/dL compared with
0.67 mg/dL on admission). Plasma NGAL was elevated in
the first sample 1:49 hours after arrest (286 ng/mL).
Urinary NGAL (2,990 ng/mL), GGT (613 U/L), π-GST
(38 μg/L), and albumin (2,900 mg/L) were elevated in the
first urine sample (6:59 hours after arrest). The patient
was oliguric (urine output of less than 0.5 mL/kg per
hour) for 19 hours from 3 hours after arrest (AKIN stage
2) and had a 3-hour period of anuria from 29 hours.
Creatinine change taking into account fluids given, urine
output, and change in GFR was modeled (Figure 7a). A
GFR decline of 75% improving to 55% after 48 hours best
represented the observed creatinine concentrations with
the minimum number of GFR changes (two). Including
Figure 2 Simulated changes in plasma creatinine and plasma volume while glomerular filtration rate was maintained. Plasma volume
(dotted lines) and plasma creatinine (solid lines) in a 70-kg male (total body water of 42 L) according to a plasma creatinine generation rate of 1
mg/minute and a baseline plasma creatinine of 1 mg/dL (equivalent to a creatinine clearance of 100 mL/minute) after an infusion of crystalloid
(black lines) or colloid (grey lines) at 1 L/hour for 6 hours.
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Figure 3 Simulated changes in plasma creatinine in the presence of reduced glomerular filtration rate (GFR). Plasma creatinine in a 70-
kg male according to a plasma creatinine generation rate of 1 mg/minute and a baseline plasma creatinine of 1 mg/dL. Values are shown
following an infusion of crystalloid (a) or colloid (b) at 1 L/hour for 6 hours. In each scenario, the creatinine curves (dark lines) are plotted for no
loss (0%) and 33.3%, 50%, and 66.7% loss of GFR (step change) at t = 1 hour. Dotted lines represent the corresponding theoretical change in
creatinine if there was no accounting for fluid balance or the 1.5%/day creatinine production reduction due to muscle wasting. Dark shading
represents acute kidney injury (AKI) by the RIFLE (Risk, Injury, Failure, Loss, and End-stage kidney disease) definition (> 50% increase in plasma
creatinine above baseline), and light shading represents AKI by the AKIN (Acute Kidney Injury Network) definition alone (> 0.3 mg/dL increase in
plasma creatinine above baseline).
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the median loss of creatinine determined from the Crde-
crease patients (Figure 5b), the best-fit GFR showed an
initial greater loss of GFR (90%). A short rapid rise in crea-
tinine at the end of the observation period was due to a
brief period of polyuria shortly prior to death (Figure 7b).
Case B: Crunchanged
Plasma creatinine remained static for the first 24 hours
before doubling prior to death. Urinary biomarkers were
all elevated in the ED sample and increased, reaching a
maximum 5 hours after arrest: NGAL 1,016 ng/mL,
cystatin C 3.0 mg/L, GGT 1,050 U/L, a-GST 34 μg/L,
and π-GST 143 μg/L. Plasma NGAL was also elevated
in the first sample: 302 ng/mL. Urine output varied
between 20 and 60 mL/hour during the first 18 hours.
The patient then showed periods of oliguria during the
ensuing 35 hours prior to death, despite large fluid
boluses.
During the first 24 hours, the retained fluid should
have resulted in a decrease in creatinine concentration
(grey line, Figure 8a). If creatinine production had also
decreased, this would have increased the expected
reduction in creatinine concentration (dotted line,
Figure 8a). Failure to observe this reduction could be
accounted for by a GFR decrease of 40% during this
period. A further reduction after 24 hours accounted for
the rapid increase in plasma creatinine.
Case C: Crdecrease
The patient received three boluses of normal saline in
the ED (totaling 1,600 mL) and four small boluses (250
to 450 mL) each hour for the first 4 hours in the ICU.
Plasma creatinine decreased more rapidly than can be
explained by dilution (Figure 9a). Urinary creatinine
decreased from 15.2 mmol/L 50 minutes after arrest to
Table 3 Cardiac arrest patient demographics (n = 49)
Demographic Value
Male 38 (78)
Age, years 61 (16)
Weight, kg 80 (13)
APACHE II score 20 (4.4)
SOFA score 8.1 (2.3)
Sepsis 4 (8)
Mechanical ventilation 49 (100)
Cooling 46 (94)
Emergency PCI 15 (31)
ROSC duration, minutes 20 (12.5-30)
DC shock, number 3 (1-5)
Adrenaline, mg 1 (0-3)
First plasma sample
B-type natriutetic peptide, pg/mL 64 (19-194)
Creatinine kinase, U/L 365 (185-920)
Troponin, μg/L 0.05 (0.03-0.175)
Creatinine, mg/dL 1.21 (1.11-1.37)
Cystatin C, mg/L 0.93 (0.77-1.11)
Urea, mmol/L 6.6 (5.4-7.8)
Outcomes
Renal replacement therapy 3 (6)
Death 23 (47%)
ICU LOS, hours 66 (48-103)
Hospital LOS, days 8.7 (3.9-14)
Data are presented as number (percentage), mean (standard deviation), or
median (lower quartile to upper quartile). APACHE II, Acute Physiology and
Chronic Health Evaluation II; DC, Direct Current; ICU, intensive care unit; LOS,
length of stay; PCI, percutaneous coronary intervention; ROSC, return of
spontaneous circulation; SOFA, Sequential Organ Failure Assessment.
Table 4 Demographic and model parameters applied to case studies
Parameter Equations Case A Case B Case C
Sex Male Male Male
Weight, kg 90 87 80
APACHE II score 26 21 19
SOFA score 12 8 4
ROSC duration, minutes 50 20 27
Time from arrest to first in-hospital plasma creatinine, minutes -91a 84 26
Total body water (TBW), mL 60 × weight in kg 54,000 52,200 48,000
Plasma volume (V10), mL TBW/15 3,600 3,480 3,200
Creatinine compartment outside of plasma (V20) TBW - plasma volume 50,400 48,720 44,800
Expandable space [16] (V2e0), mL Plasma volume × 3 10,800 10,740 9,600
Insensible loss rate (İ), mL/minute (800 mL/day) 0.56 0.56
Metabolic production rate (Ṁ), mL/minute Insensible loss rate/2 0.28 0.28
Baseline creatinine production rate [38] (Ġ), mg/minute (27 - 0.173 × age in years) × weight in kg/1,440 1.43 0.885
Distribution clearance (Cld), mL/minute 200 200 200
aAs this patient arrested in the emergency department (ED), a baseline creatinine was available on entry to the ED, 91 minutes prior to cardiac arrest. APACHE II,
Acute Physiology and Chronic Health Evaluation II; ROSC, return of spontaneous circulation; SOFA, Sequential Organ Failure Assessment.
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Figure 4 Changes in plasma creatinine concentration relative to the first creatinine measured in the emergency department followed
one of three patterns. These patterns are Crincrease (open white circles), in which the increase in plasma creatinine was greater than 20% at 24
hours after cardiac arrest; Crunchanged (closed solid circles), in which plasma creatinine increased no more than 20% or decreased no more than
10% at 24 hours after cardiac arrest, and Crdecrease, in which plasma creatinine decreased exponentially by more than 10% by 24 hours after
cardiac arrest.
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Figure 5 Changes in plasma creatinine concentration in the Crdecrease patients. (a) Median change in plasma creatinine concentration
relative to the first creatinine measured in the emergency department for Crdecrease patients. Solid circles represent raw changes. Open white
squares show changes after correction for fluid input and urine output by using the volume-creatinine kinetic model and assuming maintenance
of glomerular filtration rate. Whiskers show interquartile range. (b) The median changes in creatinine production necessary to account for the
observed reduction in plasma creatinine shown in panel (a). Crdecrease, group of patients with a plasma creatinine decrease of more than 10% at
24 hours after cardiac arrest.
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Figure 6 Kidney injury biomarkers associated with Crincrease and Crunchanged groups. Urinary and plasma neutrophil gelatinase-associated
lipocalin (NGAL) (P < 0.0001) and urinary cystatin C (P = 0.0017) showed an increasing trend, and both Crunchanged and Crincrease were
significantly different from Crdecrease (*P < 0.05, **P < 0.01, ***P < 0.001, Tukey’s multiple comparison test). Apparent trends in urinary albumin,
gamma-glutamyltranspeptidase (GGT), and π-glutahione-S-transferase (π-GST), the other biomarkers, were at a P value of greater than 0.05.
Whiskers are at 10th and 90th percentiles. Crincrease, group of patients with a plasma creatinine increase of more than 20% at 24 hours after
cardiac arrest; Crunchanged, group of patients in whom plasma creatinine increased no more than 20% or decreased no more than 10% at
24 hours after cardiac arrest.
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Figure 7 Case A: Crincrease. Effect of changing glomerular filtration rate (GFR) on calculated plasma creatinine is shown. (a) Plasma creatinine.
Open circles represent measured plasma creatinine concentrations, and solid grey lines represent modeled plasma creatinine concentrations
according to respective GFR decreases of 65%, 70%, 75%, and 85%. The dotted black line represents the best-fit modeled plasma creatinine that
results from step changes in GFR shown at the bottom of panel (a) (right axis). The solid black line represents the best fit taking into account a
loss of creatinine production, assumed to be the same as the median loss modeled for the Crdecrease group (Figure 4b), in addition to changes in
GFR. This suggests that the measured creatinine values can be explained by an immediate 90% decrease in GFR followed by two step increases
of approximately 15% in GFR with an initial decrease in creatinine production of 25%. (b) Measured fluid input (shaded area), measured urine
output (solid line), and calculated plasma volume (dashed line). The rate of fluid input initially exceeded urine output, resulting in increases in
total body water and in plasma volume. Plasma volume returned to normal toward the end of this period. Crincrease, group of patients with a
plasma creatinine increase of more than 20% at 24 hours after cardiac arrest.
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Figure 8 Case B: Crunchanged. Plasma creatinine changes (a) and fluid input/urine output and plasma volume (b) are shown. Fluids alone (no
change in glomerular filtration rate (GFR) and no reduction in creatinine production) suggest that a decrease in plasma creatinine should have
been observed (grey line). If there had been a reduction in creatinine production (Figure 4), the decrease would have been greater (dotted line).
A model including a reduction in creatinine, fluids in and out, and a reduction of 40% in GFR increasing to 90% at about 24 hours best fits the
measured creatinine. The patient became anuric despite multiple boluses and died at 53 hours. Crunchanged, group of patients in whom plasma
creatinine increased no more than 20% or decreased no more than 10% at 24 hours after cardiac arrest.
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Figure 9 Case C: Crdecrease. Plasma creatinine changes (a) and fluid input/urine output and plasma volume (b) are shown. Fluids alone cannot
account for the reduction in plasma creatinine (grey line). Either glomerular filtration rate (GFR) must be assumed to increase dramatically
followed by a decrease (dotted or lines) or there is a rapid reduction in plasma creatinine production (black lines) (see ‘Case C: Crdecrease’
subheading). Crdecrease, group of patients with a plasma creatinine decrease of more than 10% at 24 hours after cardiac arrest.
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3.1 mmol/L 3:40 hours later. It did not recover to the ear-
lier level until 42 hours after arrest. Injury biomarkers
appeared briefly elevated in the first ED sample (NGAL
347 ng/mL, cystatin C 0.54 mg/L, GGT 900 U/L, a-GST
3,800 μg/L, and π-GST 56 μg/L) but rapidly returned to
normal ranges by the first ICU sample 95 minutes later.
Discussion
The combined volume and creatinine kinetic model
clearly demonstrates that fluid resuscitation leads to an
underestimation of plasma creatinine concentration and
AKI severity or alternatively to diagnostic delay or fail-
ure to detect AKI. This strongly supports the use of an
adjusted creatinine on the basis of fluid balance, as sug-
gested by Macedo and colleagues [26]. The model
shows that the extent to which plasma creatinine was
underestimated depended on the rate of fluid infusion,
the type of fluid (crystalloid or colloid), the timing of
the plasma creatinine sample in relation to the timing of
fluid infusion, and the rate at which excess fluid was
excreted by the urine. The type of fluid minimally
affected diagnosis delay in the scenario of 6 L of fluid
given over the course of 6 hours.
AKI severity was underestimated because of fluid
loading. Even a stage 3 decrease in GFR (a decrease by
two thirds [9] by the RIFLE classification) failed to result
in an increase in plasma creatinine during infusion in
the simulated patient. The decrease in plasma creatinine
concentration was substantial (approximately 20% for
crystalloids and approximately 40% for colloids) irre-
spective of AKI severity. The rapid reduction in plasma
creatinine during fluid boluses suggests that care must
be taken in the timing of plasma sampling. If the bolus
is large, sampling should be delayed at least 1 hour.
The majority of cardiac arrest patients demonstrated a
creatinine concentration reduction that was greater than
could be explained by dilution alone. We hypothesized
that creatinine production ceased temporarily because
shock brings a temporary halt to all metabolic processes.
This could also explain a reduction in plasma cystatin C.
The relative extent of change of creatinine and cystatin C
depends on the differences in their volumes of distribu-
tion. The clinical consequences were that reliance on
plasma creatinine underestimated the severity of AKI in
the 5% of patients in whom AKI was detected (Crincrease),
and failed to classify another 8% (Crunchanged) as having
AKI. As identified by Prowle and colleagues [27], who
demonstrated that many cases of oliguria in the ICU are
not associated with increased creatinine, 41 of the 44
patients not classified as AKI by plasma creatinine in this
study developed oliguria during the first 48 hours. Injury
biomarkers confirmed that in Crunchanged there had been
substantial renal injury despite an apparently normal
plasma creatinine throughout the first 24 hours. These
patients illustrate the new category of creatinine-negative,
biomarker-positive AKI [28].
A possible explanation for poorer outcomes in patients
with AKI when nephrology consultation is delayed is that
continuing excess fluid administration results in creatinine
dilution leading to an underestimation of the severity of
the loss of renal function [29]. In a retrospective analysis
of 253 patients with AKI, Macedo and colleagues [26]
adjusted for creatinine dilution by multiplying the absolute
creatinine by the proportional increase in total body water
measured by the daily cumulative fluid balance. In 64
patients (25%), the adjusted creatinine reached the thresh-
old for AKI (50% increase) at least one day earlier than the
unadjusted creatinine. While clearly useful, this approach
does not take into account the dynamic creatinine kinetics
reported in this study, particularly with respect to timing
of sampling and the reduction in creatinine excretion rate
with increased dilution. In a prospective study, it was
shown that nephrology intervention within 18 hours trig-
gered by a plasma creatinine rise of 0.3 mg/dL reduced the
subsequent peak creatinine concentration compared with
standard practice [30]. Unfortunately, the absence of fluid
data makes it difficult to decide whether this outcome
resulted from the potential therapeutic effect of fluid load-
ing or from dilution of the creatinine concentration [31].
Several goal-directed therapy trials under way may help
to determine the therapeutic effect of fluid loading
(see ClinicalTrials.gov registered trials NCT00510835,
NCT00975793, NCT00306059, and NCT01654003).
In an ICU setting, the cost of adjusting for fluid balance
and creatinine kinetics is minimal given that urine output
is normally recorded and creatinine regularly sampled.
For most of the Crdecrease patients, creatinine concentra-
tion decreased within 4 hours. We suggest that if plasma
creatinine has not decreased after 4 hours in clinical
practice, kidney injury biomarker(s) be measured. This
obviates the expense of screening all patients and is prob-
ably within a clinically meaningful time frame with
respect to early intervention.
To the best of our knowledge, the hypothesis that
volume loading, often described as resuscitation, reverses
loss of renal function in AKI remains to be tested in a
randomized control trial. In a recent meta-analysis of
goal-directed therapy versus standard fluid administra-
tion in surgery, improved renal outcomes after AKI could
not be ascribed to administration of greater fluid volumes
[32]. The conventional paradigm of fluid administration
to maintain kidney perfusion in AKI has been challenged
by evidence suggesting that even a small positive fluid
balance contributes to increased mortality. Payen and
colleagues [33] noted that mean positive fluid balance
within 2 days of entry to the ICU was associated with
increased mortality in patients with diagnosed AKI. Simi-
larly, the percentage of fluid accumulation was lower in
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survivors than non-survivors both at AKI diagnosis and
at peak creatinine in the study by Bouchard and collea-
gues [4]. Duration of fluid overload (> 10% fluid accumu-
lation) was also associated with increased mortality. It
was noted that patients with fluid overload had lower
urine output and plasma creatinine at AKI diagnosis.
Thus, a possible contributing cause to both of these find-
ings is that patients with fluid overload on diagnosis of
AKI had, on average, a greater loss of GFR than those
without but that this was masked by dilution of plasma
creatinine.
Limitations
Because several parameters were not measureable in the
case studies, the model relied on several assumptions.
The distribution clearance was approximated to be 200
mL/minute, an expandable interstitial volume was
assumed to be three times the plasma volume, and meta-
bolic water production was assumed to be half that of the
insensible losses (at 800 mL/day). The model was not
sensitive to these parameters. We are unaware of any
experimental or clinical studies that have measured rapid
changes in creatinine production following cardiac arrest.
There is experimental, but as yet no clinical, evidence
that creatinine production may fall in sepsis by as much
as 30% [34]. It is possible that, rather than a change in
production, metabolic changes that prevent creatinine
moving between compartments may be responsible for
the phenomena observed. However, it should be noted
that our definition of Crdecrease is simply a pattern recog-
nition based on decreasing creatinine. The modeled
change in GFR in each patient may be modified if they
had loss of renal function as might be expected after a
sudden loss of renal perfusion following cardiac arrest.
The model did not take into account potential
increased capillary permeability, which is known to
occur in sepsis and possibly during therapeutic
hypothermia. Capillary leakage may reduce plasma
volume; however, colloids (albumin) have been shown in
patients with sepsis to increase the interstitial and
plasma volumes more than the volume of infused fluids,
possibly because of movement of fluid from the intracel-
lular compartment [35]. On the other hand, resuscita-
tion with cold fluids (crystalloids) appears to cause
hypovolemia despite a positive fluid balance [36,37]. All
of the case study patients underwent therapeutic
hypothermia; none was septic. If increased capillary per-
meability had resulted in hypovolemia, the plasma con-
centrations would have been artificially elevated. We
restricted analysis to cardiac arrests in order to mini-
mize heterogeneity. Further study is required to see
whether the results are generalizable to other forms of
shock.
Conclusions
The model accounts for fluid input and urine output and
helps avoid misdiagnosis of AKI and AKI severity. Creati-
nine and volume kinetics were combined to quantify
dynamic changes in GFR in the critically ill, providing
insight into disease progression. The model enabled diag-
nosis of AKI in a cohort of cardiac arrest patients despite
maintenance of a normal plasma creatinine concentra-
tion. This highlights that plasma creatinine alone cannot
be relied upon to diagnose AKI after cardiac arrest and
suggests caution in interpreting AKI epidemiology and
trials that rely solely on plasma creatinine to define out-
comes. This suggests that injury biomarkers are essential
for identifying AKI in some clinical scenarios. Volume
kinetic modeling could also enhance our understanding
of the effects of fluid loading as a mediator of poor clini-
cal outcomes [3] by quantifying the effects of fluid load-
ing on different compartments.
Key messages
• Dilution delays acute kidney injury (AKI) diagnosis.
• Avoid measurement of serum creatinine for 1 hour
after a fluid bolus.
• AKI after cardiac arrest may be missed by relying on
serum creatinine.
• A stable creatinine after cardiac arrest indicates AKI.
• Injury biomarkers are essential for identifying AKI in
some scenarios.
Additional material
Additional file 1: Extended methods and sensitivity analysis. Details
of the mathematical formulation of the combined creatinine and volume
kinetic model. Sensitivity analysis of the model input variables: the rate of
water distribution, the difference between insensible loss and metabolic
water production, variations in the ratio of the plasma to expandable
space, and creatinine generation.
Abbreviations
AKI: acute kidney injury; ALP: alkaline phosphatase; Crdecrease: group of
patients with a plasma creatinine decrease of more than 10% at 24 hours
after cardiac arrest; Crincrease: group of patients with a plasma creatinine
increase of more than 20% at 24 hours after cardiac arrest; Crunchanged: group
of patients not Crdecrease or Crincrease; ED: emergency department; GFR:
glomerular filtration rate; GGT: gamma-glutamyltranspeptidase; GST:
glutahione-S-transferase; ICU: intensive care unit; NGAL: neutrophil
gelatinase-associated lipocalin; PCI: percutaneous coronary intervention;
RIFLE: Risk, Injury, Failure, Loss, and End-stage kidney disease; ROSC: return of
spontaneous circulation.
Creatinine kinetic model: C1: creatinine concentration in the plasma
compartment; C2: creatinine concentration in the extracellular compartment;
Ġ: creatinine generation rate; ke: rate constant for diffusion of creatinine to
the plasma compartment from the extravascular compartment and vice
versa (per minute); kr: rate constant for renal excretion of creatinine from the
plasma (per minute); V1: volume of the plasma compartment; V2: volume of
the extracellular compartment.
Volume kinetic model: Ḃ: fluid infusion rate; Cld: distribution clearance (also
known as kt); İ: insensible loss rate; Ṁ: metabolic production rate; U˙: urine
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output rate; v1, v2e: expanded compartment volumes; V10: volume of the
plasma compartment at time zero; V2e0: volume of the expandable
compartment at time zero; V2n0: volume of the non-expandable
compartment (constant).
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